Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-1990 | 10-1989 | 10-1988 | 10-1987 | 10-1986 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,755 | 6,074 | 4,661 | 3,065 | 2,630 |
| Depreciation Amortization | 1,620 | 1,836 | 1,333 | 1,140 | 876 |
| Other Working Capital | -846 | -4,408 | -1,641 | -92 | 185 |
| Other Operating Activity | 355 | -348 | -913 | -2,856 | 64 |
| Operating Cash Flow | $6,884 | $3,154 | $3,440 | $1,257 | $3,755 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,042 | -2,032 | -1,875 | N/A | N/A |
| Net Acquisitions | N/A | -257 | N/A | N/A | N/A |
| Other Investing Activity | -4,291 | 269 | -960 | -7,284 | 275 |
| Investing Cash Flow | $-5,333 | $-2,020 | $-2,835 | $-7,284 | $275 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 97 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -3,462 | -206 | 580 | -347 | 100 |
| Financing Cash Flow | $-3,365 | $-206 | $580 | $-347 | $100 |
| Exchange Rate Effect | N/A | N/A | N/A | -204 | N/A |
| Beginning Cash Position | 5,614 | 4,686 | 3,501 | -2,526 | 4,039 |
| End Cash Position | 3,800 | 5,614 | 4,686 | -3,501 | 3,358 |
| Net Cash Flow | $-1,814 | $928 | $1,185 | $179 | $-50 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,884 | 3,154 | 3,440 | 1,257 | 3,755 |
| Free Cash Flow | 6,884 | 3,154 | 3,440 | 1,257 | 3,755 |